Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR-1918 in Patients With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PCSK9 Inhibitors
NCT07404553Phase 3Recruiting
- Sponsor
- Beijing Suncadia Pharmaceuticals Co., Ltd.
- Start
- Apr 2026
- Primary completion
- Jul 2028
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of SHR-1918 in hypercholesterolemia, sponsored by Beijing Suncadia Pharmaceuticals Co., Ltd.. Started Apr 2026; status: recruiting.
02
Drugs
SHR-1918
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT07404553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07404553.